Factors associated with vaccination completion and retention among HIV negative female sex workers enrolled in a simulated vaccine efficacy trial in Kampala, Uganda-Reference-Cited by-同舟云学术

Factors associated with vaccination completion and retention among HIV negative female sex workers enrolled in a simulated vaccine efficacy trial in Kampala, Uganda

Published:2019-08-16 Issue:1 Volume:19 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Mayanja Yunia,Abaasa Andrew,Namale Gertrude,Asiki Gershim,Price Matthew A.,Kamali Anatoli

Funder

International AIDS Vaccine Initiative

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-019-4328-1.pdf

Reference55 articles.

1. IAVI Trials Database, Database of Preventative HIV Vaccine Candidates. 2016. https://www.iavi.org/trials-database . Accessed 05 Jul 2018.

2. Thiam-Diouf A, Metch B, Sharpe C, Mulugrta R, Andrasik MP. Substance use patterns of HVTN phase I clinical trial participants: enrollment, risk reduction counseling and retention. Vaccine. 2018;36(9):1235–42. https://doi.org/10.1016/j.vaccine.2017.11.032 https://www.ncbi.nlm.nih.gov/pubmed/29395528 . Accessed 19 June 2018.

3. Barouch D. A step forward for HIV vaccines. Lancet HIV. 2018;5(7):338–9. https://doi.org/10.1016/S2352-3018(18)30095-X Accessed 19 June 2019.

4. Karasavvas N, Billings E, Rao M, Williams C, Zolla-Pazner S, Bailer RT, et al. The Thai phase III HIV type 1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120. AIDS Res Hum Retrovir. 2012;28(11):1444–57. https://doi.org/10.1089/aid.2012.0103 Epub 2012 Oct 4. https://www.ncbi.nlm.nih.gov/pubmed/23035746 . Accessed 04 Apr 2019.

5. Rerks-Ngarm S, Pitisuttitum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361(23):2209–20. https://doi.org/10.1056/NEJMoa0908492 Epub 2009 Oct 20. http://www.ncbi.nlm.nih.gov/pubmed/19843557 . Accessed 13 June 2018.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in hepatitis B virus healthcare service access among marginalised poor populations: a mixed-method systematic review;Infectious Diseases of Poverty;2024-08-09

2. Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda;PLOS ONE;2023-07-17

3. Predictors of participant retention in a community-based HIV prevention cohort: perspectives from the HPTN 071 (PopART) study;Trials;2023-06-27

4. Predictors of participant retention in a community-based HIV prevention cohort: perspectives from the HPTN 071 (PopART) study;2022-12-06

5. Counterfactual groups to assess treatment efficacy in HIV prevention trials in high risk populations in Uganda;2022-11-16